The Authors analyse how established criteria for quality assurance of FFP may be applied to apheresis plasma produced for fractionation into derivatives.
RobinsonE.A.Introduction and analysis of the European Society for Haemapheresis questionnaire.Transfus Sci1993; 14: 79–83.
2.
Council of Europe.Guide to the preparation, use and quality assurance of blood components.Strasburg, 1992.
3.
CollinsD.R., EntwistleC.C., FeldmanP.A., WinkelmanL., EvansH., SimsG.C.E.Fractionation of plasma derived from Baxter Autopheresis-C and Haemonetics PCS.Transfus Sci1989; 10: 295–300.
4.
FarrugiaA., SpiersD., YoungI., OatesA., HerringtonR., DamianosF.Effects of plasma collection system and processing parameters on the quality of factor IX concentrate.Vox Sang1989; 57: 4–9.
VezonG., PiquetY., ShoonemanF., MesnierF., MoulinierJ.Technical aspects of different donor plasmapheresis system and biological results obtained in collected plasma.Vox Sang1986; (Suppl 1) 51: 40–4.
7.
PerseghinP., PaganiA., FornasariP.M., SalvaneschiL.Donor plasmapheresis: a comparative study using four different types of equipment.Int J Artif Organs1987; 10: 51–6.
8.
RockG., TittleyP., FullerV.Effect of citrate anticoagulants on factor VIII levels in plasma.Transfusion1988; 28: 248–52.
9.
PennyA.F.Plasmapheresis procedure design and operation: a consideration of citrate anticoagulant usage.Transf Sci1989; 10: 51–6.
10.
DuguidJ., WinkelmanL., FeldmanP., BradyA.M.The effect of citrate anticoagulants on apheresed plasma.Transfus Sci1989; 10: 287–93.
11.
HughesC., ThomasK.B., SchiffP., HerringtonR.W., PolacsekE.E., Mc GrathK.M.Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.Transfusion1988; 28: 566–70.
12.
RockG., TittleyP.The effect of temperature variations on cryoprecipitate.Transfusion1979; 19: 86–9.
13.
CarlebjorkG., BlombackM., PihlstedtP.Freezing of plasma and recovery of factor VIII.Transfusion1986; 26: 159–62.
14.
SimonT.L.Changes in plasma coagulation factors during blood storage.Plasma Ther Transf Technol1988; 9: 309–15.
15.
International Forum.What are the critical factors in the production and quality control of frozen plasma intended for direct transfusion or for fractionation to provide medically needed labile coagulation factors?Vox Sang1983; 44: 246–59.
16.
FeldmanP., WinkelmanB.A., EvansH., PinnellM., MurdochF., SmithJ.K.A small-scale model of factor VIII and factor IX fractionation from plasma.Transfus Sci1989; 10: 279–86.
